Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01834716 · ClinicalTrials.gov registry record · NA

Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT01834716: Completed NA study, sponsored by Mayo Clinic.

NCT01834716 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01834716, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

Researchers are trying to determine if cognitively normal subjects undergoing a moderate aerobic exercise program will accumulate less amyloid-ß (Aβ) concentration in their brain than subjects undergoing a non-aerobic exercise program, and further evaluating the safety and imaging characteristics of florbetapir F 18, the radioactive drug that will allow us to image changes in the brain amyloid-ß (Aβ).

Interventions

  • BEHAVIORAL Aerobic vs. Non-Aerobic exercise

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2013-04
Est. Completion 2014-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT01834716

The ClinicalTrials.gov registry entry for NCT01834716 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Aerobic vs. Non-Aerobic exercise is the first listed.

NCT01834716 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01834716 about?

NCT01834716 is a clinical study titled "Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study". Researchers are trying to determine if cognitively normal subjects undergoing a moderate aerobic exercise program will accumulate less amyloid-ß (Aβ) concentration in their brain than subjects undergoing a non-aerobic exercise program, and further evaluating the safety and imaging characteristics of...

What is the current status of trial NCT01834716?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2013-04. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01834716?

The interventions under investigation include: Aerobic vs. Non-Aerobic exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01834716?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.